John Kiely - Nov 22, 2024 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role
Director
Signature
/s/ Denis Butkovic, Attorney-in-Fact
Stock symbol
AMRX
Transactions as of
Nov 22, 2024
Transactions value $
-$7,257
Form type
4
Date filed
11/26/2024, 04:41 PM
Previous filing
May 14, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRX Class A Common Stock Options Exercise $136K +28.5K +11.15% $4.76 284K Nov 22, 2024 Direct
transaction AMRX Class A Common Stock Sale -$143K -17.1K -6% $8.38 267K Nov 22, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMRX Stock Option Options Exercise $0 -28.5K -100% $0.00 0 Nov 22, 2024 Class A Common Stock 28.5K $4.76 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares sold to cover the exercise price arising in connection with the exercise of the stock options.
F2 The option is vested and currently exercisable.